We’re in the midst of earnings season, and a couple of San Diego’s publicly traded biotechs recently updated investors this week with sales data and other financial insights. Here’s a look... Read more »
About this time last year, DNA sequencing giant Illumina upped its financial projections, estimating its sales would grow 20 percent year-over-year. It exceeded that goal, with revenue rising 21 percent to... Read more »
The first business accelerator program in southeast San Diego is accepting applications for its second cohort of entrepreneurs, who would start the program in fall.
The six-month program, called Connect All... Read more »
HireAHelper.com, an online marketplace that links people who are moving to a new home with local movers and related services, has been acquired by Porch, which operates a marketplace that connects... Read more »
Acadia Pharmaceuticals’ treatment for Parkinson’s disease-related psychosis failed a Phase 3 trial that was studying use of the drug for schizophrenia patients who haven’t fully responded to existing therapies.
The company... Read more »
Carlsmed, a San Diego-based medical technology company that’s developing personalized spinal implants, has merged with Precisive Surgical, a spine imaging system startup in Seattle.
The combined company, which will operate in... Read more »
Comic-Con International may be holding everyone’s attention this week, but the tech community has stayed busy amid all the action (and increased traffic). Let’s catch up with the latest tech news... Read more »
Trefoil Therapeutics, which is developing treatments for diseases that affect the cornea, the outermost layer of the eye, has raised $28 million to move its lead drug candidate into human testing.... Read more »
Another company headed by former Illumina executives has launched, fueled with a $17 million Series A round from investors including a local venture capital firm.
The new firm, Cradle Genomics, is... Read more »
More than a third of the companies that went public in the first half of this year were backed by venture capital.
That, plus robust merger and acquisition activity, set a... Read more »
Eight years after San Diego biotech Prometheus Laboratories was acquired by Nestlé Health Science, the diagnostic business has been sold again, this time to a little-known biotech called Precision IBD... Read more »
In May, Amgen (NASDAQ: AMGN) revealed intriguing data from the first-ever human trial of a drug that targets tumors with a specific mutation to the gene KRAS, which occurs in... Read more »
Delivery services such as Shipt and Instacart deliver groceries to customers’ doorsteps daily. Amazon (NASDAQ: AMZN) and Walmart (NYSE: WMT) also offer the service, albeit only for their own... Read more »
San Diego is one of two metropolitan areas in which ride-hailing giant Uber has reformatted its mobile app to make it simpler for users to rent an electric bicycle or scooter.... Read more »
Brain Corp., a robotics startup whose technology powers automated floor cleaning machines in retail stores, malls, warehouses, and airports, announced Monday it is opening its first European office in Amsterdam, the... Read more »
It was a relatively quiet week in the San Diego life sciences community, but local companies and organizations continue working away. Here’s a look at some recent developments, including companies moving... Read more »
Mirati Therapeutics plans to raise more than $200 million this week in a public offering, funding that it plans to use to advance its lead cancer drug candidate, sitravatinib, into late-stage... Read more »
A company that makes a mapping system to help doctors see high-resolution, 3D images of irregular heart rhythms in real time has raised $100 million in venture investment and a $70... Read more »
Even as Uber, Lyft, and other high-profile initial public offerings underperformed out of the gate, the average share price of companies that have gone public in the US this year is... Read more »
Conatus Pharmaceuticals said Monday that it would cut its staff by 40 percent and consider a sale or merger after a drug it was testing as a treatment for an increasingly... Read more »